CXCR4 and metabolic dysfunction-associated steatotic liver disease: CXCR4 was highly expressed on CD16- monocyte subsets (Fig 3B) and, like CXCR3, increased in patients with HCV but not NAFLD, regardless of disease stage (Fig 3C).